Market Exclusive

THERMO FISHER SCIENTIFIC INC. (NYSE:TMO) Files An 8-K Submission of Matters to a Vote of Security Holders

THERMO FISHER SCIENTIFIC INC. (NYSE:TMO) Files An 8-K Submission of Matters to a Vote of Security Holders

Item 5.07 Submission of Matters to a Vote of Security Holders

At the annual meeting of stockholders of Thermo Fisher Scientific
Inc. (the Company) held on May 17, 2017, the stockholders of the
Company voted on the following proposals:
1.
The following nominees were elected to the Companys Board
of Directors for a one-year term expiring at the 2018
annual meeting of stockholders.
For
Against
Abstain
Broker
Non-Votes
Marc N. Casper
326,787,322
226,539
226,007
22,970,135
Nelson J. Chai
324,328,812
2,681,617
229,439
22,970,135
C. Martin Harris
324,782,594
2,223,276
233,998
22,970,135
Tyler Jacks
325,454,052
1,556,084
229,732
22,970,135
Judy C. Lewent
326,836,277
181,463
222,128
22,970,135
Thomas J. Lynch
300,323,298
26,689,977
226,593
22,970,135
Jim P. Manzi
324,047,214
2,965,220
227,434
22,970,135
William G. Parrett
293,232,814
32,347,584
1,659,470
22,970,135
Lars R. Srensen
325,436,119
432,111
1,371,638
22,970,135
Scott M. Sperling
325,081,854
1,928,630
229,384
22,970,135
Elaine S. Ullian
320,617,051
6,404,998
217,819
22,970,135
Dion J. Weisler
324,323,038
2,681,178
235,652
22,970,135
2.
A non-binding, advisory proposal on the compensation of the
Companys named executive officers was approved.
For:
271,697,468
Against:
54,821,033
Abstain:
721,367
Broker Non-Votes:
22,970,135
3.
The stockholders recommended, in a non-binding advisory
vote, that future advisory votes on the compensation of the
Company’s named executive officers be held every year.
Every 1 Year:
301,056,188
Every 2 Years:
572,004
Every 3 Years:
25,072,678
Abstain:
538,998
After taking into consideration the foregoing voting results, the
Company intends to hold future advisory votes on the compensation
of the Companys named executive officers every year.
>4.
The appointment of PricewaterhouseCoopers LLP as the
independent registered public accounting firm for the
Company for the fiscal year ending December 31, 2017 was
ratified.
For:
340,516,332
Against:
9,216,678
Abstain:
476,993
THERMO FISHER SCIENTIFIC INC.

About THERMO FISHER SCIENTIFIC INC. (NYSE:TMO)
Thermo Fisher Scientific Inc. develops, manufactures and sells a range of products. The Company is a provider of analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. The company operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. Through the Life Sciences Solutions segment, it provides reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines, as well as diagnosis of disease. Through the Analytical Instruments segment, it provides instruments, consumables, software and services. The Specialty Diagnostics segment offers diagnostic test kits, reagents, culture media, instruments and associated products. The Laboratory Products and Services segment offers self-manufactured and sourced products for the laboratory. THERMO FISHER SCIENTIFIC INC. (NYSE:TMO) Recent Trading Information
THERMO FISHER SCIENTIFIC INC. (NYSE:TMO) closed its last trading session up +0.77 at 171.74 with 1,367,983 shares trading hands.

Exit mobile version